Revolution Medicines, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.28B +153.6% €92.16M -119.7% 7.2% +1.0 pp N/A N/A
    (estimated) €503.07M +265.8% -€467.60M -50.7% -93.0% +6.0 pp N/A N/A
    (estimated) €137.54M +534.8% -€948.87M -3.9% -689.9% +39 pp -€1.02B +2.3% -740.0% +39 pp
    (estimated) €21.66M +284.3% -€987.09M +14.0% -4,556.1% +110 pp -€995.04M +31.7% -4,592.9% +88 pp
    (estimated) €5.64M +∞% -€865.93M +69.2% -15,358.9% -150 pp -€755.62M +61.9% -13,402.3% -130 pp
    €0.00 -100.0% -€511.85M +37.5% N/A -€466.67M +59.6% N/A
    €9.88M -67.3% -€372.20M +75.5% -3,768.3% -31 pp -€292.43M +60.5% -2,960.6% -24 pp
    €30.18M +20.4% -€212.13M +38.3% -703.0% -0.91 pp -€182.18M +51.9% -603.7% -1.3 pp
    €25.07M -31.6% -€153.34M +66.2% -611.7% -3.6 pp -€119.97M +44.8% -478.6% -2.5 pp
    €36.66M -14.1% -€92.25M +126.9% -251.6% -1.6 pp -€82.85M +106.5% -226.0% -1.3 pp
    €42.68M +148.2% -€40.66M +14.1% -95.2% +1.1 pp -€40.11M -1,834.0% -94.0% -1.1 pp
    €17.20M +∞% -€35.64M +34.3% -207.2% -2.1 pp €2.31M -111.5% 13.4% +0.13 pp
    €0.00 -€26.55M N/A -€20.11M N/A

    Notifications